The TIMI risk score predicted mortality in patients with ST-elevation myocardial infarction

Ray, Joel
March 2002
ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p76
Academic Journal
Focuses on a study which examined the accuracy of Thrombolysis in Myocardial Infarction risk score for predicting in-hospital, or all-cause mortality in patients with ST-elevation myocardial infarction. Methodology of the study; Results; Comments on the study.


Related Articles

  • Treatment Delay Increases Mortality After Myocardial Infarction. Rose, Verna L.; Berger, Alan K. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3157 

    Presents a summary of a study presented at the 48th Annual Scientific Session of the American College of Cardiology which showed that patients with delayed thrombolytic therapy are at increased risk of mortality after myocardial infarction.

  • Mortality benefit of thrombolytic, antiarrhythmic agents in MI therapy praised.  // Formulary;May96, Vol. 31 Issue 5, p411 

    Discusses the mortality benefit of thrombolytic and antiarrhythmic agents in myocardial infarction (MI) therapy. Study challenging angioplasty's superiority over thrombolysis for acute MI; Amiodarone's reduction of mortality due to arrhythmia in post-MI patients; Benefit of angiotensin...

  • Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. French, John K.; Williams, Barbara F. // BMJ: British Medical Journal (International Edition);6/29/96, Vol. 312 Issue 7047, p1637 

    Determines the proportion of patients presenting with acute myocardial infarction who are eligible for thrombolytic therapy in Auckland, New Zealand. Eligibility for thrombolytic therapy; Mortality rates of myocardial infarction patients; Cautions with thrombolytic therapy. INSET: Key messages..

  • Time delays in provision of thrombolytic treatment in six district. Birkhead, J.S. // BMJ: British Medical Journal (International Edition);8/22/92, Vol. 305 Issue 6851, p445 

    Measures the delay between onset of symptoms and admission to hospital and provision of thrombolysis in patients acute myocardial infarction. Response time by patients; Trends in emergency services; Reduction of symptoms to thrombolysis by more effective use of emergency services.

  • Intracoronary Thrombolysis in Evolving Myocardial Infarction. Ganz, William // Annals of Internal Medicine;Oct81, Vol. 95 Issue 4, p500 

    Editorial. Comments on the intracoronary thrombolysis in evolving myocardial infarction. Morbidity and mortality of myocardial necrosis; Time limit set for considering patients for reperfusion; Clinical studies with intracoronary thrombolysis.

  • Outcome of Patients with Acute Myocardial Infarction Who Are Ineligible for Thrombolytic Therapy. Cragg, David R.; Friedman, Harold Z.; Bonema, John D.; Jaiyesimi, Ishmael A.; Ramos, Renato G.; Timmins, Gerald C.; O'Neill, William; Schreiber, Theodore L. // Annals of Internal Medicine;8/1/91, Vol. 115 Issue 3, p173 

    Focuses on a study which determined the outcome of patients with acute myocardial infarction, who are ineligible for thrombolytic therapy. Information on thrombolytic therapy; Methodology of the study; Results and discussion.

  • Increased prescription of thrombolytic treatment to elderly patients with suspected acute myocardial infarction associated with audit. Hendra, Timothy J.; Marshall, Andrew J. // BMJ: British Medical Journal (International Edition);2/15/92, Vol. 304 Issue 6824, p423 

    Evaluates the prescription of thrombolytic treatment to elderly patients with suspected myocardial infarction. Analysis of prescriptions and uptake of treatment; Impact on the increase of prescription of thrombolytic treatment; Relation of streptokinase treatment with transient arrhythmias.

  • The delay to thrombolysis: An analysis of hospital and patient characteristics. Brophy, James M.; Diodati, Jean G.; Bogaty, Peter; Theroux, Pierre // CMAJ: Canadian Medical Association Journal;02/24/98, Vol. 158 Issue 4, p475 

    Presents research which studied various components of the delay to thrombolytic treatment for patients with acute myocardial infarction (MI). Identification of hospital and patient characteristics related to delay; Design; Setting; Subjects; Main outcome measures; Hesitation of patients to seek...

  • Thrombolytic therapy is underused in the elderly. Krumholz, H.M.; Murillo, J.E. // RN;Dec97, Vol. 60 Issue 12, p16 

    Reports that according to researcher at the Yale School of Medicine who studied 3, 093 myocardial infarction (MI) patients, many elderly are eligible for thrombolytic theraphy but do not receive it. Number of patients examined who received the theraphy; Detailed information on the results of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics